(2R,3R,4S,5S,6R)-2-(((1R,2S,3R,4R,6R)-3,6-dihydroxy-2-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1,5,6-Trideoxy-4-O-?-D-glucopyranosyl-1-[[(1S,4R,5S,6S)-3-[(?-D-glucopyranosyloxy)methyl]-4,5,6-trihydroxy-2-cyclohexen-1-yl]amino]-5-(hydroxymethyl)-D-chiro-inositol;
Validamycin C is a fully characterized chemical compound used as a reference standard of API Validamycin. The standard offered is compliant with regulatory guidelines. Validamycin C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 12650-70-3
